Faculty of Pharmaceutical Sciences, University of Ilorin, Ilorin, Nigeria.
Faculty of Pharmaceutical Sciences, University of Port Harcourt, Choba, Nigeria.
Int J Health Plann Manage. 2021 Jan;36(1):13-17. doi: 10.1002/hpm.3067. Epub 2020 Aug 28.
The COVID-19 pandemic continues to be a major public health threat globally and low- and middle-income countries (LMICs) are not an exception. The impact of the COVID-19 pandemic is far-reaching on many areas including but not limited to global health security, economic and healthcare delivery with a potential impact on access to healthcare in LMICs. We evaluate the impact of the COVID-19 pandemic on access to healthcare in LMICs, as well as plausible strategies that can be put in place to ensure that the delivery of healthcare is not halted. In order to mitigate the devastating effect of the COVID-19 pandemic on the already weak health systems in LMICs, it is much necessary to reinforce and scale up interventions and proactive measures that will ensure that access to healthcare is not disrupted even in course of the pandemic.
译文： 新冠疫情仍然是全球主要的公共卫生威胁，中低收入国家（LMICs）也不例外。新冠疫情的影响广泛，包括但不限于全球卫生安全、经济和医疗保健服务，可能会影响到 LMICs 获得医疗保健的机会。我们评估了新冠疫情对 LMICs 获得医疗保健的影响，以及可以采取的合理策略，以确保医疗保健服务不会中断。为了减轻新冠疫情对 LMICs 本已脆弱的卫生系统的破坏性影响，有必要加强和扩大干预措施和主动措施，以确保即使在疫情期间也不会中断获得医疗保健的机会。
